The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells
$ 18.00
-
By A Mystery Man Writer
-
-
4.8(106)
Product Description
Mechanisms of drug resistance, including efflux pump-mediated
Crizotinib‐based proteolysis targeting chimera suppresses gastric cancer by promoting MET degradation - Chen - 2023 - Cancer Science - Wiley Online Library
Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer, Journal of Nanobiotechnology
IJMS, Free Full-Text
Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery
Biopharmaceutics and Drug Disposition, Pharmacology Journal
October, 2022
Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review - ScienceDirect
Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review - ScienceDirect
MDR1 Drug Efflux Pump Promotes Intrinsic and Acquired Resistance to PROTACs in Cancer Cells
